Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on the next-generation sequencing informatics market provides an in-depth analysis of segments and sub-segments in the global as well as regional next-generation sequencing informatics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional next-generation sequencing informatics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global next-generation sequencing informatics market. According to the report, the global next-generation sequencing informatics market is projected to grow at a CAGR of 20% over the forecast period of 2021-2027.
The revenue generated by the market was USD 2621 million in 2021 and is expected to reach USD 7677 million in 2027. Next-generation sequencing is a DNA sequencing method that
determines the exact arrangement of nucleotides within a DNA molecule. A huge
parallelization in this technology allows millions and billions of DNA strands
to be sequenced. Novel informatics services, products, and solutions are being
developed for next-generation sequencing around the world. The growing scope of next-generation sequencing will prompt the deployment of NSG informatics tools
and services that would enable to dynamically view and management data and
significantly reduce the time of NGS processes. With a growing number of
bioinformatics companies entering the market to offer next-generation NGS
informatics products and services, the growth of the market is expected to be
exponential. NGS informatics products and services majorly include NGS
Informatics Services, Data Analysis & Management Tools, and Primary and
Secondary Data Analysis Tools with a wide range of applications in Drug
Discovery, Diagnostics, Genetic Screening, and various others.
Next-generation sequencing (NGS)
is transforming clinical laboratories and has a direct and profound impact on
precision medicine, patient care, and bioinformatics. Equally the applications
of NGS in clinical diagnostics are rapidly growing. NGS systems' high-throughput
abilities have resulted in a massive accumulation of sequence data. Therefore,
the demand for NGS Informatics tools and services has increased severalfold to
manage the sequenced data. The growing applications of NGS in the clinical
environment have been detrimental to the development of NGS informatics
infrastructure and solutions. Additionally, the adoption of smart computing
technology and tools based on cloud computing to leverage the Big Data in NGS
is majorly driving the market. Cloud computing enables the rapid development of
products and services with faster turnaround times for NGS processes. The
growth of the market may be restrained due to the limited availability of skilled
expertise. Nevertheless, new growth opportunities are expected to rise as new
technologies such as AI and ML are being integrated with NGS informatics
products and services.
North America is expected to
dominate the market over the forecast period. According to the Centers for Disease
Control and Prevention (CDC), 6 out of 10 USA citizens suffer from at least one
of the chronic diseases such as cancer, heart disease, stroke, and diabetes.
According to American Cancer Society Journals, there will be around 1,918,030
new cancer cases and 609,360 cancer deaths in the USA alone in 2022. According to
CDC, 34 million people in the USA had diabetes in 2020. Given such widespread of
chronic diseases in North America, clinical diagnosis through next-generation
Sequencing of these diseases is expected to increase. This is also expected to
increase the adoption of NGS Informatics products and services across research institutions, clinical laboratories, pharmaceutical companies, and
biotechnological companies using Next-Generation Sequencing. Multiple market
players such as Agilent Technologies Inc., Illumina, Inc., DNAnexus, Inc.,
PerkinElmer, Inc, and others are based in North America is the domestic market
for them.
The report on the global
next-generation sequencing informatics market covers segments such as product
and services, application, and end users. On the basis of product and services,
the sub-markets include NGS informatics services, data analysis &
management tools, and primary and secondary data analysis tools. On the basis
of application, the sub-markets include drug discovery, diagnostics, genetic
screening, precision medicine, agriculture and animal research, and others. On
the basis of end users, the sub-markets include hospitals, academic and
research institutions, pharamceutical companies, biotechnology companies, and others.
The report provides profiles of
the companies in the market such as Agilent Technologies Inc., Illumina, Inc.,
F. Hoffmann-La Roche AG, DNAnexus, Inc., Qiagen N.V., Partek
Incorporated, Intrexon Bioinformatics Germany GmbH, Sapio Sciences, PerkinElmer,
Inc, and Thermo Fisher Scientific Inc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the next-generation sequencing informatics market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.